Skip to main content
. 2022 Mar 7;14(5):1360. doi: 10.3390/cancers14051360

Figure 3.

Figure 3

(A) Differences in amounts of cell populations between healthy reactive lymph nodes (RLNs) and classic Hodgkin lymphoma (cHL) samples. (B) Classification of cell types and immune signatures with respect to favorable or unfavorable outcomes in cHL patients.